Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study

INTRODUCTION: The risk for stroke in adults with congenital heart disease (ACHD) is increased, especially in the setting of commonly ensuing atrial arrhythmias (AA), namely atrial fibrillation, atrial flutter or intra-atrial re-entrant tachycardia. Data are limited regarding treatment with non-vitam...

Descripción completa

Detalles Bibliográficos
Autores principales: Kartas, Anastasios, Doundoulakis, Ioannis, Ntiloudi, Despoina, Koutsakis, Athanasios, Kosmidis, Diamantis, Rampidis, Georgios, Apostolopoulou, Sotiria, Frogoudaki, Alexandra, Tzifa, Afrodite, Avramidis, Dimosthenis, Ntzoyvara, Olga, Liori, Sotiria, Mousiama, Tereza, Mouratoglou, Sophia Anastasia, Karvounis, Haralambos, Giannakoulas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509965/
https://www.ncbi.nlm.nih.gov/pubmed/32963069
http://dx.doi.org/10.1136/bmjopen-2020-038012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509965/
https://www.ncbi.nlm.nih.gov/pubmed/32963069
http://dx.doi.org/10.1136/bmjopen-2020-038012

Ejemplares similares